BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12603693)

  • 1. Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects.
    Handgretinger R; Klingebiel T; Lang P; Gordon P; Niethammer D
    Pediatr Transplant; 2003; 7 Suppl 3():51-5. PubMed ID: 12603693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation.
    Oevermann L; Lang P; Feuchtinger T; Schumm M; Teltschik HM; Schlegel P; Handgretinger R
    Ann N Y Acad Sci; 2012 Aug; 1266():161-70. PubMed ID: 22901267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency.
    Martín-Hernández MP; Arrieta R; Martínez A; García P; Jimenez-Yuste V; Hernandez-Navarro F
    Bone Marrow Transplant; 1997 Nov; 20(9):797-9. PubMed ID: 9384486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
    Handgretinger R; Klingebiel T; Lang P; Schumm M; Neu S; Geiselhart A; Bader P; Schlegel PG; Greil J; Stachel D; Herzog RJ; Niethammer D
    Bone Marrow Transplant; 2001 Apr; 27(8):777-83. PubMed ID: 11477433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.
    Li Pira G; Malaspina D; Girolami E; Biagini S; Cicchetti E; Conflitti G; Broglia M; Ceccarelli S; Lazzaro S; Pagliara D; Meschini A; Bertaina A; Montanari M; Locatelli F
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2056-2064. PubMed ID: 27519279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches to graft engineering for haploidentical bone marrow transplantation.
    Handgretinger R
    Semin Oncol; 2012 Dec; 39(6):664-73. PubMed ID: 23206843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity.
    Aversa F; Martelli MF; Velardi A
    Semin Oncol; 2012 Dec; 39(6):643-52. PubMed ID: 23206841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of individualized graft composition: CD3/CD19 depletion combined with CD34 selection for haploidentical transplantation.
    Huenecke S; Bremm M; Cappel C; Esser R; Quaiser A; Bonig H; Jarisch A; Soerensen J; Klingebiel T; Bader P; Koehl U
    Transfusion; 2016 Sep; 56(9):2336-45. PubMed ID: 27346253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of megadoses of purified haploidentical stem cells.
    Handgretinger R; Schumm M; Lang P; Greil J; Reiter A; Bader P; Niethammer D; Klingebiel T
    Ann N Y Acad Sci; 1999 Apr; 872():351-61; discussion 361-2. PubMed ID: 10372137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An effective method for T-cell and B-cell simultaneous depletion in vitro from mobilized peripheral blood stem/progenitor cell graft for haploidentical transplantation].
    Xiao J; Li HH; Jin XS; Jin HJ; Fu LY; Gao CJ; Han XP; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1126-9. PubMed ID: 18928610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
    Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
    Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The history and future prospective of haplo-identical stem cell transplantation.
    Handgretinger R; Lang P
    Cytotherapy; 2008; 10(5):443-51. PubMed ID: 18615344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical bone marrow transplantation without T-cell depletion.
    Chang YJ; Huang XJ
    Semin Oncol; 2012 Dec; 39(6):653-63. PubMed ID: 23206842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
    Brodszki N; Turkiewicz D; Toporski J; Truedsson L; Dykes J
    Orphanet J Rare Dis; 2016 Jan; 11():5. PubMed ID: 26768987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor Selection Based on Killer Cell Immunoglobulin-Like Receptor (KIR) Genotype May Improve Outcome After T-Cell-Replete Haploidentical Transplantation.
    Torío A; Pascual MJ; Vidales I; Ortiz M; Caballero A; Heiniger AI
    Transplant Proc; 2018 Mar; 50(2):679-682. PubMed ID: 29579887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell depletion in paediatric stem cell transplantation.
    Booth C; Veys P
    Clin Exp Immunol; 2013 May; 172(2):139-47. PubMed ID: 23574311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transplantation of highly purified CD34+ hematologic peripheral stem cells from haploidentical related donors in the treatment of children with non-malignant diseases].
    Starý J; Sedlácek P; Vodvárková S; Poloucková A; Formánková R; Gasová Z; Marinov I
    Cas Lek Cesk; 2002 Mar; 141(6):176-81. PubMed ID: 11977835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in haploidentical stem cell transplantation for hematologic malignancies.
    Montoro J; Sanz J; Sanz GF; Sanz MA
    Leuk Lymphoma; 2016 Aug; 57(8):1766-75. PubMed ID: 27424663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34(+) cells and a fixed CD3(+) dose.
    Dvorak CC; Gilman AL; Horn B; Oon CY; Dunn EA; Baxter-Lowe LA; Cowan MJ
    Bone Marrow Transplant; 2013 Apr; 48(4):508-13. PubMed ID: 23178543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.